Llwytho...
Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review
Nivolumab is a checkpoint inhibiting immunotherapeutic agent prescribed for the treatment of resistant cancers. Many immune-related adverse effects including neurological effects have been described, but central nervous system (CNS) toxicities are rarely reported. We present a 59-year-old Caucasian...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Med Res |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Marshfield Clinic
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6546281/ https://ncbi.nlm.nih.gov/pubmed/31160476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2019.1417 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|